期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

如何规范应用导管溶栓术治疗动脉闭塞性疾病 被引量：9

How to Standardize the Application of Catheter-directed Thrombolysis in Treatment of Arterial Occlusive Disease
下载PDF
导出
摘要 应用灌注导管实施的动脉溶栓术——导管接触性溶栓术(catheter-directed thrombolysis,CDT)因具有药物作用直接、用药量少、全身不良反应少及手术创伤小等优点,目前已成为合并血栓形成的动脉闭塞性疾病的有效治疗方法之一。而如何规范应用CDT对达到其有效性及安全性至关重要。对此临床医师应明确掌握CDT治疗动脉闭塞性疾病的适应证及禁忌证、CDT的技术要点、术后并发症的种类及防治措施,以使患者获得最大收益。 Depending on its special advantages such as direct effect of medications, low dose, fewer systemic adverse effects and traumas, catheter-directed thrombolysis （CDT） has become one of the effective treatments for arterial occlusive disease. Standardized application of CDT is vital to ensure its efficacy and safety. Therefore, clinical physicians should master the indications, contraindications, technical points of CDT, postoperative complications and corresponding control measures so as to maximatily apply the optimal treatment for patients.
作者 包俊敏 梅志军
机构地区 第二军医大学附属长海医院血管外科全军血管外科研究所
出处 《临床误诊误治》 2014年第3期42-45,共4页 Clinical Misdiagnosis & Mistherapy
关键词 动脉闭塞性疾病 导管 机械溶栓 规范 治疗应用 Arterial occlusive disease Catheters Pharmaceutical thrombolysis Standard Therapeutic uses
分类号 R543.5 [医药卫生—心血管疾病]
  • 相关文献

参考文献7

  • 1包俊敏.下肢动脉闭塞性疾病腔内治疗进展[J].中国普外基础与临床杂志,2010,17(7):645-648. 被引量：23
  • 2Alonso-Coello P, Bellmunt S, McGorrian C, et al. An- tithrombotic therapy in peripheral artery disease: an- tithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines[ J]. Chest, 2012,141 ( Suppl 2 ) : S669-S690.
  • 3Marder V J, Comerota A J, Shlansky-Goldberg R D, et al. Safety of catheter-delivered plasmin in patients with a- cute lower extremity arterial or bypass graft occlusion: phase I results [ J]. J Thromb Haemost, 2012, 10 (6) : 985-991.
  • 4Weaver F A, Comerota A J, Youngblood M, et al. Surgi- cal revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a pro- spective randomized trial. The STILE Investigators. Sur- gery versus Thrombolysis for Ischemia of the Lower Ex- tremity [ J ]. J Vasc Surg, 1996,24 ( 4 ) : 513-521.
  • 5Hodgson T J, Gaines P A, Beard J D. Thrombolysis and angioplasty for acute lower limb ischemia in Buergerg dis- ease[ J]. Cardiovasc Intervent Radiol, 1994,17 (6) :333- 335.
  • 6Norgren L, Hiatt W R, Dormandy J A, et al. Inter-socie- ty consensus for the management of peripheral arterial dis- ease . Int Angiol, 2007,26 ( 2 ) : 81-157.
  • 7Mahler F, Schneider E, Hess H, et al. Recombinant tis- sue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions : a prospective, randomized multicenter trial[ J]. J Endovasc Ther, 2001, 8(6) :638-647.

二级参考文献28

  • 1Siablis D, Kraniotis P, Karnabatidis D, et al. Sirolimuseluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month anglographic results from a nonrandomized prospective single-center study [J]. J Endovasc Ther, 2005; 12(6): 685- 695.
  • 2Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimus-eluring versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia : enduring 1-year angiographic and clinical benefit [J]. J Endovasc Ther, 2007; 14(2) : 241- 250.
  • 3Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues [J]. J Endovasc Ther, 2009; 16 Suppl I : I 153- I 162.
  • 4Kickuth R, Keo HH, Triller J, et al. Initial clinical experience with the 4 F self expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia [J]. J Vasc Interv Radiol, 2007; 18 (6) : 703-708.
  • 5Norgren L, Hiatt WR,Dormandy JA, et al. Inter society consensus for the management of peripheral arterial disease (TASCⅡ) [J]. J Vasc Surg, 2007; 45 Suppl S: S5-S67.
  • 6Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review [J]. Cardiovasc Intervent Radiol, 2008, 31 (4): 687-697.
  • 7Ruckert RI, Tsilimparis N, Lobenstein B, et al. Midterm results of a precuffed expanded polytetrafluoroethylene graft for above knee femoropopliteal bypass in a multicenter study [J]. J Vasc Surg, 2009; 49(5): 1203 -1209.
  • 8McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTgE/nitinol self expanding stem graft vs pros thetic femoral popliteal bypass in the treatment of superficial femoral artery occlusive disease [J]. J Vasc Surg, 2009; 49 (1): 109- 116.
  • 9Faglia E, Cleriei G, Clerissi J, et al. Long-term prognosis of diabetic patients with critical limb ischemia: a populationbased cohort study [J]. Diabetes Care, 2009; 32(5): 822- 827.
  • 10Graziani L, Silvestro A, Bertone V, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease [J]. Nephrol Dial Transplant, 2007; 22(4): 1144 -1149.

共引文献22

同被引文献83

引证文献9

二级引证文献85

临床误诊误治
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部